404 Error
Open Webinar to Explore Impact of REMS on U.S. Healthcare Payers
May 5, 2010WILMINGTON, DE, May 5, 2010 – The role of healthcare payers is increasingly becoming the focus in how FDA-mandated REMS – Risk Evaluation and Mitigation Strategies intended to increase safe drug use – are impacting the practice of medicine in the U.S., and that subject will be examined in an open webinar next Wednesday, May 12, at 12 noon Eastern Time.
Entitled “REMS Challenges: The Payer’s Perspective,” it is the sixth in a series of monthly “Wednesday FoREMS” webinars sponsored by ParagonRx, an inVentiv Health, Inc. company (Nasdaq: VTIV) and a leading consulting company specializing in pharmaceutical risk management and optimizing medication use.
Leading the discussion will be Jennifer Restivo, vice president and managing director at inVentiv Advance Insight, who will present her research on:
- How payers integrate REMS into utilization management practices
- Success factors in collaboration between manufacturers and payers
- Approaches that encourage REMS implementation and utilization
More information about registering for the “Wednesday FoREMS” webinar series can be found at www.paragonrx.com/rems-hub/forems/. Webinars will be held the second Wednesday of each month at 12 noon EST.
